Study for Evaluation of Murlentamab (GM102) Anti-tumoral Activity in Colorectal Cancers
Clinical trial NCT03799731 · COMPLETED
Trial details
- NCT number
- NCT03799731
- Sponsor
- GamaMabs Pharma
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-07-11
- Primary completion
- 2021-01-19
- Enrollment
- 65
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.